Replies to post #5912 on Arch Therapeutics Inc (ARTH)

[regalmanor]

Per the 2/16/2017 PR, "Arch is maintaining current guidance regarding its aim to file a CE Mark for AC5 Topical Hemostatic Device™ as soon as possible and is continuing to work with its third-party partners to prepare requisite materials for submission to regulatory authorities. As previously stated, the planned 2017 regulatory filings would be the company's first, as there has not yet been a submission for approval of AC5 to any regulatory body".

[21money21]

No they don't have a specific date, they are talking about htgm and how it took them 2 1/2 months from file date until approval